These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18688993)

  • 1. Assess HIV/HCV patients' response to interferon. Non-responders gain nothing from treatment.
    AIDS Alert; 2008 Jul; 23(7):76-7. PubMed ID: 18688993
    [No Abstract]   [Full Text] [Related]  

  • 2. [HIV and HCV infections--clinical implications].
    Pawłowska M; Halota W; Grabczewska E
    Przegl Epidemiol; 2004; 58 Suppl 1():71-5. PubMed ID: 15807161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.
    Martini F; Sacchi A; Lalle E; Castilletti C; D'Offizi G; Abbate I; Capobianchi MR
    Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-virus response and interferon, cytokine systems in patients with chronic hepatitis C].
    Makashova VV; Florianu AI
    Ter Arkh; 2008; 80(11):7-10. PubMed ID: 19143182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Almost 6,000 double-infected patients in Germany. Hepatitis C burden in HIV patients].
    MMW Fortschr Med; 2000; 142(3 Suppl):19. PubMed ID: 10893954
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV/HCV coinfection. A good chance of recovery also for dually infected patients].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():7. PubMed ID: 25026843
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic hepatitis C in HIV-infected patients: from clinical trials to field practice.
    Piroth L; Martha B; Minello A; Grappin M; Chavanet P
    Scand J Infect Dis; 2008; 40(6-7):561-4. PubMed ID: 18584548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullet points: new topics in HIV/AIDS.
    Laurence J
    AIDS Patient Care STDS; 2002 Jan; 16(1):1-4. PubMed ID: 11839212
    [No Abstract]   [Full Text] [Related]  

  • 9. [HIV plus hepatitis C or Kaposi sarcoma. Treatment options in coinfection].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():58-9. PubMed ID: 10863315
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic hepatitis B].
    Mauss S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():48-51. PubMed ID: 19031564
    [No Abstract]   [Full Text] [Related]  

  • 11. Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.
    Vogel M; Bertram N; Wasmuth JC; Wyen C; Voigt E; Schwarze-Zander C; Sudhop T; Fätkenheuer G; Rockstroh JK; Reichel C
    J Antimicrob Chemother; 2009 May; 63(5):988-91. PubMed ID: 19270314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
    Inglot M; Szymczak A; Gasiorowski J
    Przegl Epidemiol; 2008; 62(2):383-91. PubMed ID: 18807485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A 38-year old HIV infected male with neurological focality during treatment of hepatitis].
    Ruiz Seco MP; Salinero Paniagua E
    Rev Clin Esp; 2011 Oct; 211(9):464-71. PubMed ID: 21839432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [News about HIV. Combination therapy with new drugs gives hope].
    Sönnerborg A; Julander I
    Lakartidningen; 1996 Feb; 93(6):451-2. PubMed ID: 8637320
    [No Abstract]   [Full Text] [Related]  

  • 16. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV clinical trials in Rhode Island.
    Skowron G
    R I Med; 1993 Sep; 76(9):473-8. PubMed ID: 8219398
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
    Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
    Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.